Elon

Delta

Elon Musk

Gains

<div class="textg" style="text-align: justify; font-weight: lighter; line-height: 1.3em; font-size: 15px; border-radius: 3px; color: #80909a; padding: 10px; background-color: #F4F6F9; margin-bottom: 15px;">
 Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our&nbsp;<a href="https://tokenist.com/terms-of-service/" style="text-decoration:underline;color:#3c7b7b" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">website policy</a>&nbsp;prior to making financial decisions.
</div>
<p class="has-drop-cap">In a volatile trading session, Delta Air Lines (NYSE: DAL), Tesla (NASDAQ: TSLA), and Pfizer (NYSE: PFE) are making headlines with significant stock movements and company developments.<br><br>As of 12:46 PM EDT, these three stocks are drawing investor attention for various reasons, ranging from earnings reports to product developments and market debates.</p>
<h3 id="delta-air-lines-dal-tumbles-on-weak-guidance">Delta Air Lines (DAL) Tumbles on Weak Guidance</h3>
<p>Delta Air Lines shares plummeted 5.04% to $44.50 following the release of <a href="https://tokenist.com/delta-air-lines-misses-revenue-expectations-in-q2-eps-in-line/" rel="noopener noreferrer nofollow" class="deco-link">mixed second-quarter results</a> and disappointing third-quarter guidance. The airline reported Q2 operating revenue of $16.7 billion and adjusted earnings per share of $2.36, meeting expectations.<br><br>However, its Q3 EPS forecast of $1.70-$2.00 fell short of analyst projections, triggering a <a href="https://tokenist.com/airline-stocks-face-turbulence-after-delta-posts-weak-q3-guidance/" rel="noopener noreferrer nofollow" class="deco-link">broad selloff in airline stocks</a>.</p>
<p>The weak guidance highlighted ongoing challenges in the airline industry, including excess capacity and pricing pressures. Delta’s announcement impacted other major carriers, with United Airlines (NASDAQ: UAL) down 16.07%, American Airlines (NASDAQ: AAL) plunging 40.69%, and Southwest Airlines (NYSE: LUV) dropping 27.80%.</p>
<p>Despite the current setback, Delta’s stock maintains a year-to-date gain of 11.18%, outperforming its one-year return of -7.25%.</p>
<div class="cta-referral"><img src="https://tokenist.com/wp-content/themes/thetokenist/assets/img/del/cta-referral-1.png" alt="" class="cta-referral__img" loading="lazy" decoding="async">
 <div class="cta-referral__text">
  <p>Join our&nbsp;<a href="https://t.me/thetokenist" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">Telegram group&nbsp;and never miss a breaking story.</a></p>
 </div>
</div>
<h3 id="tesla-tsla-faces-volatility-amid-market-debate">Tesla (TSLA) Faces Volatility Amid Market Debate</h3>
<p>Tesla’s stock experienced a sharp decline of 6.23% to $246.86, potentially ending its <a href="https://tokenist.com/how-tesla-energy-can-play-a-big-role-in-the-companys-evolution-beyond-cars/" rel="noopener noreferrer nofollow" class="deco-link">recent 11-day winning streak</a>.<br><br>The electric vehicle maker found itself at the center of a market debate after Bill Gross, the “Bond King,” criticized its stock performance, claiming Tesla was “<a href="https://tokenist.com/rearview-mirror-or-windshield-musk-responds-to-bill-gross-tesla-criticism/" class="deco-link" rel="noopener noreferrer nofollow">acting like a meme stock</a>” with “sagging fundamentals.”</p>
<p>CEO Elon Musk swiftly responded, asserting that Gross “does not understand technology.” The exchange highlighted differing views on Tesla’s market position and valuation.<br><br>Adding to the day’s volatility, reports emerged suggesting a delay in the company’s robotaxi unveiling event. Despite the day’s losses, Tesla’s stock has surged nearly 50% over the past month, although it remains down 0.68% year-to-date.</p>
<h3 id="pfizer-pfe-gains-on-weight-loss-drug-development">Pfizer (PFE) Gains on Weight Loss Drug Development</h3>
<p>Pfizer’s stock rose 1.60% to $28.80 following the announcement of its <a href="https://tokenist.com/wall-street-weighs-in-as-pfizer-targets-100-billion-weight-loss-market/" rel="noopener noreferrer nofollow" class="deco-link">plans to advance a once-daily version of its weight loss pill</a>, danuglipron.<br><br>The decision, based on encouraging early-stage trial results, keeps Pfizer in contention for a share of the projected $100 billion GLP-1 market.</p>
<p>The company plans additional early-stage trials for the second half of 2024, with results expected in Q1 2025.<br><br>This development signals Pfizer’s focus on internal growth rather than late-stage acquisitions and maintains competitive pressure on market leaders Novo Nordisk and Eli Lilly (NYSE: LLY).<br><br>While Pfizer’s stock is up 3.09% year-to-date, it has underperformed the broader market, with the S&amp;P 500 gaining 18.14% over the same period.</p> <iframe src="https://tokenist.substack.com/embed" width="100%" height="320" style="border:1px solid #EEE; background:white;" frameborder="0" scrolling="no"></iframe>
<p><em>Disclaimer: The author does not hold or have a position in any securities discussed in the article.</em></p>
<h3 id="br"><br></h3>
<p>The post <a rel="noopener noreferrer nofollow" href="https://tokenist.com/stocks-to-watch-today-delta-air-lines-tesla-and-pfizer/">Stocks to Watch Today: Delta Air Lines, Tesla, and Pfizer</a> appeared first on <a rel="noopener noreferrer nofollow" href="https://tokenist.com">Tokenist</a>.</p>

Stocks to Watch Today: Delta Air Lines, Tesla, and Pfizer

目次

Tokenist

2024年7月11日公開の他の記事

DWF Labs Reaffirms Web3 Expansion Amid Market Challenges (11 Jul)

Compound Finance site potentially breached — ZachXBT

This Firm Launches New Bitcoin ETF In The US With Colossal 200% Daily Profit Targets – Details

Is This The Next Big Altcoin During The Upcoming Bull Rally?

Binance Expands Offerings with New Trading Pairs and Bot Services

Early Twitter, Uber Investor Naval Ravikant Says 'Bitcoin Is A Tool For Underdogs' As Trump Gears...

ニュースレターを購読して暗号資産の最新情報を毎日入手！